Impact of Delirium on Distress, Health-Related Quality of Life, and Cognition 6 Months and 1 Year after Hematopoietic Cell Transplant

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 6, 2010, Pages 824-831

  Basinski, James R ^a   Alfano, Catherine M ^b   Katon, Wayne J ^a   Syrjala, Karen L ^a,c   Fann, Jesse R ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cognition; Delirum; Distress; Outcomes; Quality of life; Stem cell transplantation

Indexed keywords

ADULT; ARTICLE; CELL TRANSPLANTATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DELIRIUM; DEPRESSION; DISTRESS SYNDROME; FATIGUE; FEMALE; HEALTH STATUS; HEMATOPOIETIC CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL HEALTH; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PROGNOSIS; QUALITY OF LIFE;

ADULT; ANXIETY; BREAST NEOPLASMS; COGNITION DISORDERS; DELIRIUM; DEPRESSION; FATIGUE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; MOOD DISORDERS; OVARIAN NEOPLASMS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952584482     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.01.003     Document Type: Article

References (40)

1. Beglinger L.J., Duff K., Van Der Heiden S., Parrott K., Langbehn D., Gingrich R. Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients. Biol Blood Marrow Transplant 2006, 12:928-935.
2. Fann J.R., Roth-Roemer S., Burington B.E., Katon W.J., Syrjala K.L. Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer 2002, 95:1971-1981.
3. Han L., McCusker J., Cole M., Abrahamowicz M., Primeau F., Elie M. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001, 161:1099-1105.
4. Andrykowski M.A., Altmaier E.M., Barnett R.L., Burish T.G., Gingrich R., Henslee-Downey P.J. Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation. Bone Marrow Transplant 1990, 6:269-276.
5. Julin J.E., van Burik J.H., Krivit W., et al. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. Transpl Infect Dis 2002, 4:201-206.
6. American Psychiatric Association American Psychiatric Association, Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th ed.
7. Fann J.R. The epidemiology of delirium: a review of studies and methodological issues. Semin Clin Neuropsychiatr 2000, 5:64-74.
8. Caraceni A., Nanni O., Maltoni M., et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer 2000, 89:1145-1149.
9. Lawlor P.G., Gagnon B., Mancini I.L., et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000, 160:786-794.
10. Ljubisavljevic V., Kelly B. Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 2003, 25:345-352.
11. Syrjala K.L., Langer S.L., Abrams J.R., et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004, 291:2335-2343.
12. Syrjala K.L., Dikmen S., Langer S.L., Roth-Roemer S., Abrams J.R. Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood 2004, 104:3386-3392.
13. Harder H., Van Gool A.R., Duivenvoorden H.J., et al. Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: two-year follow-up results. Eur J Cancer 2007, 43:2052-2059.
14. Fann J.R., Alfano C.M., Roth-Roemer S., Katon W.J., Syrjala K.L. Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation. J Clin Oncol 2007, 25:1223-1231.
15. Trzepacz P.T., Baker R.W., Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988, 23:89-97.
16. Derogatis L.R. The SCL-90 1975, Clinical Psychometrics Research, Baltimore, MD.
17. Derogatis L.R., Morrow G.R., Fetting J., et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983, 249:751-757.
18. Cella D.F., Jacobsen P.B., Orav E.J., Holland J.C., Silberfarb P.M., Rafla S. A brief POMS measure of distress for cancer patients. J Chronic Dis 1987, 40:939-942.
19. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613.
20. Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
21. Levin H.S., High W.M., Goethe K.E., et al. The neurobehavioural rating scale: assessment of the behavioural sequelae of head injury by the clinician. J Neurol Neurosurg Psychiatry 1987, 50:183-193.
22. Sunderland A.H.J., Baddely A. Do laboratory tests predict everyday memory? A neuropsychological study. J Verb Learn Verb Behav 1983, 22:341-357.
23. Mickey R.M., Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989, 129:125-137.
24. Thompson W.D. Statistical analysis of case-control studies. Epidemiol Rev 1994, 16:33-50.
25. Glymour M.M., Weuve J., Berkman L.F., Kawachi I., Robins J.M. When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol 2005, 162:267-278.
26. McCusker J., Cole M., Dendukuri N., Belzile E., Primeau F. Delirium in older medical inpatients and subsequent cognitive and functional status: a prospective study. CMAJ 2001, 165:575-583.
27. Francis J., Kapoor W.N. Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc 1992, 40:601-606.
28. Rockwood K., Cosway S., Carver D., Jarrett P., Stadnyk K., Fisk J. The risk of dementia and death after delirium. Age Ageing 1999, 28:551-556.
29. Dolan M.M., Hawkes W.G., Zimmerman S.I., et al. Delirium on hospital admission in aged hip fracture patients: prediction of mortality and 2-year functional outcomes. J Gerontol A Biol Sci Med Sci 2000, 55:M527-M534.
30. Cole M.G., You Y., McCusker J., Ciampi A., Belzile E. The 6 and 12 month outcomes of older medical inpatients who recover from delirium. Int J Geriatr Psychiatry 2008, 23:301-307.
31. Gruber-Baldini A.L., Zimmerman S., Morrison R.S., et al. Cognitive impairment in hip fracture patients: timing of detection and longitudinal follow-up. J Am Geriatr Soc 2003, 51:1227-1236.
32. Andrykowski M.A., Schmitt F.A., Gregg M.E., Brady M.J., Lamb D.G., Henslee-Downey P.J. Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer 1992, 70:2288-2297.
33. Seaman J.S., Schillerstrom J., Carroll D., Brown T.M. Impaired oxidative metabolism precipitates delirium: a study of 101 ICU patients. Psychosomatics 2006, 47:56-61.
34. Fricchione G.L., Nejad S.H., Esses J.A., et al. Postoperative delirium. Am J Psychiatry 2008, 165:803-812.
35. Alsop D.C., Fearing M.A., Johnson K., Sperling R., Fong T.G., Inouye S.K. The role of neuroimaging in elucidating delirium pathophysiology. J Gerontol A Biol Sci Med Sci 2006, 61:1287-1293.
36. Jackson J.C., Gordon S.M., Hart R.P., Hopkins R.O., Ely E.W. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev 2004, 14:87-98.
37. Alexopoulos G.S., Kiosses D.N., Heo M., Murphy C.F., Shanmugham B., Gunning-Dixon F. Executive dysfunction and the course of geriatric depression. Biol Psychiatry 2005, 58:204-210.
38. Levy-Cooperman N., Burhan A.M., Rafi-Tari S., et al. Frontal lobe hypoperfusion and depressive symptoms in Alzheimer disease. J Psychiatry Neurosci 2008, 33:218-226.
39. Davydow D.S. Symptoms of depression and anxiety after delirium. Psychosomatics 2009, 50:309-316.
40. Marcantonio E.R., Flacker J.M., Michaels M., Resnick N.M. Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc 2000, 48:618-624.